Pathomechanisms in channelopathies of skeletal muscle and brain.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Annual Review of Neuroscience

• Publication date

  2006-06-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1146/ANNUREV.NEURO.29.051605.112815PMID 16776591
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The wide spectrum of spinocerebellar ataxias (SCAs)

  2008cited by this paper
• Depression of extra-cellular GABA and increase of NMDA-induced nitric oxide following acute intra-nuclear administration of alcohol in the cerebellar nuclei of the rat

  2008cited by this paper
• Dysfunction of the brain calcium channel CaV2.1 in absence epilepsy and episodic ataxia.

  2005cited by this paper
• Sodium channel dysfunction in intractable childhood epilepsy with generalized tonic–clonic seizures

  2005cited by this paper
• Muscle channelopathies and critical points in functional and genetic studies.

  2005cited by this paper
• Ion channel defects in idiopathic epilepsies.

  2005cited by this paper
• Mutation in the neuronal voltage-gated sodium channel SCN1A in familial hemiplegic migraine.

  2005cited by this paper
• Function and dysfunction of synaptic calcium channels: insights from mouse models.

  2005cited by this paper
• Sodium channel mutations in epilepsy and other neurological disorders.

  2005cited by this paper
• Calcium-sensitive potassium channelopathy in human epilepsy and paroxysmal movement disorder

  2005cited by this paper
• Clinical spectrum of episodic ataxia type 2

  2004cited by this paper
• Mice Lacking Sodium Channel β1 Subunits Display Defects in Neuronal Excitability, Sodium Channel Expression, and Nodal Architecture

  2004cited by this paper
• A Cacna1a knockin migraine mouse model with increased susceptibility to cortical spreading depression.

  2004cited by this paper
• Dysfunction of the brain calcium channel CaV2.1 in absence epilepsy and episodic ataxia

  2004cited by this paper
• A Novel Hyperekplexia-causing Mutation in the Pre-transmembrane Segment 1 of the Human Glycine Receptor α1 Subunit Reduces Membrane Expression and Impairs Gating by Agonists*

  2004cited by this paper
• Focal caspase activation underlies the endplate myopathy in slow‐channel syndrome

  2004cited by this paper
• Genetic mechanisms that underlie epilepsy

  2004cited by this paper
• Polyglutamine repeats of spinocerebellar ataxia 6 impair the cell-death-preventing effect of CaV2.1 Ca2+ channel--loss-of-function cellular model of SCA6.

  2004cited by this paper
• Noninactivating voltage-gated sodium channels in severe myoclonic epilepsy of infancy.

  2004cited by this paper
• Increased sensitivity to agonist-induced seizures, straub tail, and hippocampal theta rhythm in knock-in mice carrying hypersensitive alpha 4 nicotinic receptors.

  2003cited by this paper
• A mouse model of episodic ataxia type-1

  2003cited by this paper
• Increased Sensitivity to Agonist-Induced Seizures, Straub Tail, and Hippocampal Theta Rhythm in Knock-In Mice Carrying Hypersensitive α4 Nicotinic Receptors

  2003cited by this paper
• Mutations in CLCN2 encoding a voltage-gated chloride channel are associated with idiopathic generalized epilepsies

  2003cited by this paper
• Myasthenic syndrome caused by mutation of the SCN4A sodium channel

  2003cited by this paper
• Haploinsufficiency of ATP1A2 encoding the Na+/K+ pump α2 subunit associated with familial hemiplegic migraine type 2

  2003cited by this paper
• A deletion in SCN1B is associated with febrile seizures and early-onset absence epilepsy

  2003cited by this paper
• Neurological diseases: Sleuthing molecular targets for neurological diseases at the neuromuscular junction

  2003cited by this paper
• X-ray structure of a ClC chloride channel at 3.0 Å reveals the molecular basis of anion selectivity

  2002cited by this paper
• Myotonia caused by mutations in the muscle chloride channel gene CLCN1

  2002cited by this paper
• Hyperekplexia associated with compound heterozygote mutations in the beta-subunit of the human inhibitory glycine receptor (GLRB).

  2002cited by this paper
• Familial hemiplegic migraine mutations increase Ca2+ influx through single human CaV2.1 channels and decrease maximal CaV2.1 current density in neurons

  2002cited by this paper
• Expanded CUG repeats trigger aberrant splicing of ClC-1 chloride channel pre-mRNA and hyperexcitability of skeletal muscle in myotonic dystrophy.

  2002cited by this paper
• Active Calcium Accumulation Underlies Severe Weakness in a Panel of Mice with Slow-Channel Syndrome

  2002cited by this paper
• Disease-Specific Human Glycine Receptor α1 Subunit Causes Hyperekplexia Phenotype and Impaired Glycine- and GABAA-Receptor Transmission in Transgenic Mice

  2002cited by this paper
• Novel CLCN1 mutations with unique clinical and electrophysiological consequences.

  2002cited by this paper
• Mutation of GABRA1 in an autosomal dominant form of juvenile myoclonic epilepsy

  2002cited by this paper
• An expanding view for the molecular basis of familial periodic paralysis.

  2002cited by this paper
• Loss-of-function EA2 mutations are associated with impaired neuromuscular transmission

  2001cited by this paper
• Mutant GABA(A) receptor gamma2-subunit in childhood absence epilepsy and febrile seizures.

  2001cited by this paper
• Complete loss of P/Q calcium channel activity caused by a CACNA1A missense mutation carried by patients with episodic ataxia type 2.

  2001cited by this paper
• Hypokalaemic periodic paralysis type 2 caused by mutations at codon 672 in the muscle sodium channel gene SCN4A.

  2001cited by this paper
• Mutant GABAA receptor γ2-subunit in childhood absence epilepsy and febrile seizures

  2001cited by this paper
• Increased Expression of α1A Ca2+Channel Currents Arising from Expanded Trinucleotide Repeats in Spinocerebellar Ataxia Type 6

  2001cited by this paper
• First genetic evidence of GABAA receptor dysfunction in epilepsy: a mutation in the γ2-subunit gene

  2001cited by this paper
• Mutations in Kir2.1 cause the developmental and episodic electrical phenotypes of Andersen's syndrome.

  2001cited by this paper
• Myotonic Dystrophy Type 2 Caused by a CCTG Expansion in Intron 1 of ZNF9

  2001cited by this paper
• De novo mutations in the sodium-channel gene SCN1A cause severe myoclonic epilepsy of infancy.

  2001cited by this paper
• The Human Skeletal Muscle Na Channel Mutation R669H Associated with Hypokalemic Periodic Paralysis Enhances Slow Inactivation

  2000cited by this paper
• The Polyglutamine Expansion in Spinocerebellar Ataxia Type 6 Causes a β Subunit-Specific Enhanced Activation of P/Q-Type Calcium Channels in Xenopus Oocytes

  2000cited by this paper
• Voltage-sensor sodium channel mutations cause hypokalemic periodic paralysis type 2 by enhanced inactivation and reduced current.

  2000cited by this paper
• Spectrum of sodium channel disturbances in the nondystrophic myotonias and periodic paralyses.

  2000cited by this paper
• Targeted disruption of Kir2.1 and Kir2.2 genes reveals the essential role of the inwardly rectifying K(+) current in K(+)-mediated vasodilation.

  2000cited by this paper
• Ablation of P/Q-type Ca(2+) channel currents, altered synaptic transmission, and progressive ataxia in mice lacking the alpha(1A)-subunit.

  1999cited by this paper
• Voltage-gated ion channels and hereditary disease.

  1999cited by this paper
• Defective slow inactivation of sodium channels contributes to familial periodic paralysis

  1999cited by this paper
• Effects of mutations causing hypokalaemic periodic paralysis on the skeletal muscle L‐type Ca2+ channel expressed in Xenopus laevis oocytes

  1999cited by this paper
• Insulin acts in hypokalemic periodic paralysis by reducing inward rectifier K+ current.

  1999cited by this paper
• Electrical myotonia in heterozygous carriers of recessive myotonia congenita

  1999cited by this paper
• Direct Alteration of the P/Q-Type Ca2+ Channel Property by Polyglutamine Expansion in Spinocerebellar Ataxia 6

  1999cited by this paper
• A novel mutation in the human voltage-gated potassium channel gene (Kv1.1) associates with episodic ataxia type 1 and sometimes with partial epilepsy.

  1999cited by this paper
• Impairment of skeletal muscle adenosine triphosphate-sensitive K+ channels in patients with hypokalemic periodic paralysis.

  1999cited by this paper
• A potassium channel mutation in neonatal human epilepsy.

  1998cited by this paper
• Deletion of the K(V)1.1 potassium channel causes epilepsy in mice.

  1998cited by this paper
• KCNQ2 and KCNQ3 potassium channel subunits: molecular correlates of the M-channel.

  1998cited by this paper
• Episodic Ataxia Mutations in Kv1.1 Alter Potassium Channel Function by Dominant Negative Effects or Haploinsufficiency

  1998cited by this paper
• Febrile seizures and generalized epilepsy associated with a mutation in the Na+-channel ß1 subunit gene SCN1B

  1998cited by this paper
• Radicals r'aging

  1998cited by this paper
• Calcium currents and transients of native and heterologously expressed mutant skeletal muscle DHP receptor α1 subunits (R528H)

  1998cited by this paper
• Molecular features of the CAG repeats of spinocerebellar ataxia 6 (SCA6).

  1997cited by this paper
• Mutation in the M1 Domain of the Acetylcholine Receptor α Subunit Decreases the Rate of Agonist Dissociation

  1997cited by this paper
• Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the α1A-voltage-dependent calcium channel

  1997cited by this paper
• Hypokalemic periodic paralysis: an autosomal dominant muscle disorder caused by mutations in a voltage-gated calcium channel.

  1997cited by this paper
• A mutation in autosomal dominant myotonia congenita affects pore properties of the muscle chloride channel.

  1997cited by this paper
• Inactivation defects caused by myotonia-associated mutations in the sodium channel III-IV linker

  1996cited by this paper
• End-plate acetylcholine receptor deficiency due to nonsense mutations in the epsilon subunit.

  1996cited by this paper
• Congenital Myasthenic Syndrome Caused by Decreased Agonist Binding Affinity Due to a Mutation in the Acetylcholine Receptor ε Subunit

  1996cited by this paper
• Familial Hemiplegic Migraine and Episodic Ataxia Type-2 Are Caused by Mutations in the Ca Channel

  1996cited by this paper
• Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4.

  1996cited by this paper
• A GLRA1 null mutation in recessive hyperekplexia challenges the functional role of glycine receptors.

  1996cited by this paper
• End‐plate acetylcholine receptor deficiency due to nonsense mutations in the ε subunit

  1996cited by this paper
• Congenital myasthenic syndrome caused by decreased agonist binding affinity due to a mutation in the acetylcholine receptor epsilon subunit.

  1996cited by this paper
• A missense mutation in the neuronal nicotinic acetylcholine receptor α4 subunit is associated with autosomal dominant nocturnal frontal lobe epilepsy

  1995cited by this paper
• Different effects on gating of three myotonia‐causing mutations in the inactivation gate of the human muscle sodium channel.

  1995cited by this paper
• An aspartic acid residue important for voltage-dependent gating of human muscle chloride channels.

  1995cited by this paper
• Andersen's syndrome: Potassium‐sensitive periodic paralysis, ventricular ectopy, and dysmorphic features

  1994cited by this paper
• Dihydropyridine receptor mutations cause hypokalemic periodic paralysis.

  1994cited by this paper
• Mapping of the hypokalaemic periodic paralysis (HypoPP) locus to chromosome 1q31–32 in three European families

  1994cited by this paper
• Episodic ataxia/myokymia syndrome is associated with point mutations in the human potassium channel gene, KCNA1

  1994cited by this paper
• A calcium channel mutation causing hypokalemic periodic paralysis.

  1994cited by this paper
• Sodium channel mutations in paramyotonia congenita exhibit similar biophysical phenotypes in vitro.

  1994cited by this paper
• Evidence for recessive as well as dominant forms of startle disease (hyperekplexia) caused by mutations in the alpha 1 subunit of the inhibitory glycine receptor.

  1994cited by this paper
• Mutations in the α1 subunit of the inhibitory glycine receptor cause the dominant neurologic disorder, hyperekplexia

  1993cited by this paper
• Genetic heterogeneity in benign familial neonatal convulsions: identification of a new locus on chromosome 8q.

  1993cited by this paper
• Functional consequences of a Na+ channel mutation causing hyperkalemic periodic paralysis.

  1993cited by this paper
• Functional expression of sodium channel mutations identified in families with periodic paralysis.

  1993cited by this paper
• Non-dystrophic myotonias and periodic paralyses. A European Neuromuscular Center Workshop held 4-6 October 1992, Ulm, Germany.

  1993cited by this paper
• Theoretical reconstruction of myotonia and paralysis caused by incomplete inactivation of sodium channels.

  1993cited by this paper
• Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3' end of a transcript encoding a protein kinase family member.

  1992cited by this paper
• Hyperkalemic periodic paralysis and the adult muscle sodium channel alpha-subunit gene.

  1990cited by this paper
• Benign familial neonatal convulsions linked to genetic markers on chromosome 20

  1989cited by this paper

• The Lie Group Basis of Neuronal Membrane Architecture: Why the Hodgkin–Huxley Equations Take Their Form

  2026cites this paper
• Atomistic Simulation of Voltage Activation of a Truncated BK Channel

  2025cites this paper
• Insights into tissue- and cell type-specific effects of Grb10 on pig skeletal muscle growth by multi-omics analysis

  2025cites this paper
• Atomistic simulation of voltage activation of a truncated BK channel

  2025cites this paper
• Autoimmune Fanconi Syndrome Presenting with Hypokalemic Paralysis in a Young Adult: A Renal-limited Sjögren Variant

  2025cites this paper
• Modulatory Impact of Oxidative Stress on Action Potentials in Pathophysiological States: A Comprehensive Review

  2024cites this paper
• Pediatric neuromuscular channelopathies.

  2024cites this paper
• Self-reported outcomes and quality of life of patients with non-dystrophic myotonia: The French IMPACT 2022 survey.

  2024cites this paper
• Mexiletine versus lamotrigine in non-dystrophic myotonias: a randomised, double-blind, head-to-head, crossover, non-inferiority, phase 3 trial.

  2024cites this paper
• Synergistic Effect of Brevetoxin BTX-3 and Ciguatoxin CTX3C in Human Voltage-Gated Nav1.6 Sodium Channels

  2023cites this paper
• Biomimetic lipid membranes: An overview on their properties and applications

  2023cites this paper
• Muscle channelopathies.

  2023cites this paper
• Non‐dystrophic myotonia: 2‐year clinical and patient reported outcomes

  2022cites this paper
• In silico versus functional characterization of genetic variants: lessons from muscle channelopathies.

  2022cites this paper
• Muscle Channelopathies

  2022cites this paper
• Periodic paralysis due to cumulative effects of rare variants in SCN4A with small functional alterations

  2022cites this paper
• Editorial: Emerging perspectives in sodium channelopathies

  2022cites this paper
• Terahertz Wave Enhances Permeability of the Voltage-Gated Calcium Channel.

  2021cites this paper
• Cannabidiol inhibits the skeletal muscle Nav1.4 by blocking its pore and by altering membrane elasticity

  2021cites this paper
• Cannabidiol Selectively Binds to the Voltage-Gated Sodium Channel Nav1.4 in Its Slow-Inactivated State and Inhibits Sodium Current

  2021cites this paper
• The Dragon’s Paralysing Spell: Evidence of Sodium and Calcium Ion Channel Binding Neurotoxins in Helodermatid and Varanid Lizard Venoms

  2021cites this paper
• Morphological Alterations of the Sarcotubular System in Permanent Myopathy of Hereditary Hypokalemic Periodic Paralysis with a Mutation in the CACNA1S Gene.

  2020cites this paper
• An Up-to-Date Overview of the Complexity of Genotype-Phenotype Relationships in Myotonic Channelopathies

  2020cites this paper
• Mechanism and effects of the skeletal muscle Nav1.4 inhibition by cannabidiol

  2020cites this paper
• Hereditary myotonia in American Bulldog associated with a novel frameshift mutation in the CLCN1 gene.

  2020cites this paper
• Guidelines on clinical presentation and management of nondystrophic myotonias

  2020cites this paper
• Lower Ca2+ enhances the K+-induced force depression in normal and HyperKPP mouse muscles

  2020cites this paper
• Defective Gating and Proteostasis of Human ClC-1 Chloride Channel: Molecular Pathophysiology of Myotonia Congenita

  2020cites this paper
• Protonation state of the selectivity filter of bacterial voltage‐gated sodium channels is modulated by ions

  2020cites this paper
• Electromyographic Features in a Chinese Cohort With Hereditary Skeletal Muscle Channelopathies.

  2020cites this paper
• Improving genetic diagnostics of skeletal muscle channelopathies

  2020cites this paper
• EF hand‐like motif mutations of Nav1.4 C‐terminus cause myotonic syndrome by impairing fast inactivation

  2020cites this paper
• Biological applications of tethered bilayer lipid membranes.

  2019cites this paper
• Herculean Boy With Facial Myokymia.

  2019cites this paper
• Pathological findings in a patient with non-dystrophic myotonia with a mutation of the SCN4A gene; a case report

  2019cites this paper
• An integrative methodology based on protein-protein interaction networks for identification and functional annotation of disease-relevant genes applied to channelopathies

  2019cites this paper
• Congenital Myopathies and Related Diseases

  2018cites this paper
• Clinical Features of Skeletal Muscle and Their Underlying Molecular Mechanism

  2018cites this paper
• Skeletal Muscle Channelopathies

  2018cites this paper
• Developing models to study the mechanisms of weakness and myotonia in Periodic Paralysis

  2018influential citation
• Secreted Cysteine-Rich Repeat Proteins “SCREPs”: A Novel Multi-Domain Architecture

  2018cites this paper
• Using voltage‐sensor toxins and their molecular targets to investigate NaV1.8 gating

  2018cites this paper
• Effects of acidosis on neuronal voltage-gated sodium channels: Nav1.1 and Nav1.3

  2018cites this paper
• Improving the characterization of calcium channel gating pore currents with Stac3

  2018cites this paper
• Pain in SCN4A Mutated P.A1156T muscle sodium channelopathy—a postal survey

  2018cites this paper
• In vivo assessment of muscle membrane properties in the sodium channel myotonias

  2018cites this paper
• بررسی جهش در اگزون 8 ژن CLCN1 در بیماران ایرانی مبتلا به میوتونی غیر دیستروفیک

  2017cites this paper
• Persistent Inward Currents Play a Role in Muscle Dysfunction Seen inMyotonia Congenita

  2017cites this paper
• Dichlorphenamide efficacy in the primary periodic paralyses

  2017cites this paper
• Down-regulation of Kir2.6 channel by c-termini mutation D252N and its association with the susceptibility to Thyrotoxic Periodic Paralysis.

  2017influential citation
• The study of mutation in exon 8 of CLCN1 gene in Iranian non-dystrophic myotonia patients

  2017cites this paper
• A Mixed Periodic Paralysis & Myotonia Mutant, P1158S, Imparts pH-Sensitivity in Skeletal Muscle Voltage-gated Sodium Channels

  2017cites this paper
• Episodic weakness and Charcot–marie–tooth disease due to a mitochondrial MT‐ATP6 mutation

  2017cites this paper
• EMG-signal processing for neuro-excitability tests using Matlab

  2017cites this paper
• The Potential of Modulating Na+ K+ Atpase Pumps and Katp Channels in the Development of a New Therapy to Treat Hyperkalemic Periodic Paralysis

  2017influential citation
• An unusual case of sodium channel myotonia with transient weakness upon initiating movements which is characteristic in Becker disease.

  2017cites this paper
• Sodium channel NaV1.9 mutations associated with insensitivity to pain dampen neuronal excitability

  2017cites this paper
• AMPK As A Target in Rare Diseases.

  2016cites this paper
• The hitchhiker’s guide to the voltage-gated sodium channel galaxy

  2016cites this paper
• Profiling neuronal ion channelopathies with non-invasive brain imaging and dynamic causal models: Case studies of single gene mutations

  2016influential citation
• Physiology and Pathophysiology of Sodium Channel Inactivation.

  2016cites this paper
• A recessive Nav1.4 mutation underlies congenital myasthenic syndrome with periodic paralysis

  2016cites this paper
• A case of non-dystrophic myotonia with concomitant mutations in the SCN4A and CLCN1 genes.

  2016cites this paper
• Genetic and molecular studies of skeletal muscle channelopathies

  2016cites this paper
• Chapter 28 – Rodent Models of Autosomal Dominant Primary Dystonia

  2015cites this paper
• Channelopathies of skeletal muscle excitability.

  2015influential citation
• Towards a Unified Theory of Calmodulin Regulation (Calmodulation) of Voltage-Gated Calcium and Sodium Channels.

  2015cites this paper
• SCN4A mutation as modifying factor of myotonic dystrophy type 2 phenotype.

  2015cites this paper
• Understanding the physiology of the asymptomatic diaphragm of the M1592V hyperkalemic periodic paralysis mouse

  2015cites this paper
• [Omega pore, an alternative ion channel permeation pathway involved in the development of several channelopathies].

  2015cites this paper
• Physiological basis for muscle stiffness and weakness in a knock‐in M1592V mouse model of hyperkalemic periodic paralysis

  2015influential citation
• Molecular Surface of JZTX-V (β-Theraphotoxin-Cj2a) Interacting with Voltage-Gated Sodium Channel Subtype NaV1.4

  2014cites this paper
• Nondystrophic myotonia: challenges and future directions.

  2014cites this paper
• Biophysics, pathophysiology, and pharmacology of ion channel gating pores

  2014cites this paper
• Evidence for Functional Diversity between the Voltage-Gated Proton Channel Hv1 and Its Closest Related Protein HVRP1

  2014cites this paper
• Muscle channelopathies: recent advances in genetics, pathophysiology and therapy.

  2014cites this paper
• Treatment and Management of Neuromuscular Channelopathies

  2014cites this paper
• Domain III S4 in closed-state fast inactivation: Insights from a periodic paralysis mutation

  2014cites this paper
• Clinical Profile in Hypokalemic Periodic Paralysis Cases

  2014cites this paper
• Disorders of Skeletal Muscle Membrane Excitability: Myotonia Congenita, Paramyotonia Congenita, Periodic Paralysis, and Related Syndromes

  2014cites this paper
• Muscle channelopathies.

  2014cites this paper
• Novel mutations in human and mouse SCN4A implicate AMPK in myotonia and periodic paralysis

  2014cites this paper
• The voltage sensor module in sodium channels.

  2014cites this paper
• Disrupted coupling of gating charge displacement to Na+ current activation for DIIS4 mutations in hypokalemic periodic paralysis

  2014cites this paper
• Reduction In Skeletal Muscle Chloride Conductance Improves Contractile Force In Wildtype, But Not In Hyperkalemic Periodic Paralysis Mice

  2014cites this paper
• Forensic Aspects of Adult and General Neuropathology JAN E. LEESTMA

  2014cites this paper
• The diagnosis and treatment of myotonic disorders

  2013cites this paper
• Voltage-Gated Sodium Channels: Structure, Function, and Pathophysiology

  2013cites this paper
• Age‐dependent chloride channel expression in skeletal muscle fibres of normal and HSALR myotonic mice

  2013cites this paper
• Inherited Ion channel disorders of the brain

  2013cites this paper
• Web-based neuromuscular simulator applied to the teaching of principles of neuroscience

  2013cites this paper
• Engineering animal models of dystonia

  2013cites this paper
• Effects of metabolism upon neuronal activity and synaptic performance

  2013cites this paper
• A review of potassium channels in bipolar disorder

  2013cites this paper
• Molecular Genetics of Skeletal Muscle Channelopathies

  2013cites this paper
• Muscle Channelopathies: the Nondystrophic Myotonias and Periodic Paralyses

  2013influential citation
• Potassium and the Dyskalemias

  2013cites this paper
• Stress, caffeine and ethanol trigger transient neurological dysfunction through shared mechanisms in a mouse calcium channelopathy.

  2013cites this paper
• Correction: S1–S3 counter charges in the voltage sensor module of a mammalian sodium channel regulate fast inactivation

  2013cites this paper
• Teaching Video NeuroImages: Cold-induced eyelid myotonia

  2013cites this paper